FDA approves Wellbutrin XL to treat seasonal affective disorder
The FDA yesterday approved GlaxoSmithKline’s Wellbutrin XL (bupropion HCL extended release tablets) for prevention of major depressive episodes in patients ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.